home / news releases


Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

Now Trending

Company Name:Lexicon Pharmaceuticals Inc.
Stock Symbol:LXRX
Market:NASDAQ
Website:lexpharma.com

Menu

LXRX LXRX Quote LXRX Short LXRX News LXRX Articles LXRX Message Board
Get Alerts

News, Short Squeeze, Breakout and More Instantly...

Search News Releases

ENSG - The Ensign Group Reports Second Quarter 2024 Results; Raises Annual Earnings and Revenue Guidance

SAN JUAN CAPISTRANO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of companies, which provide post-acute healthcare services and invest in the long-term healthcare industry, primarily in skilled nursing and senior livi...

AAOI - Applied Optoelectronics Confirms No Material Impact to Operations from Typhoon Gaemi

SUGAR LAND, Texas and TAIPEI, Taiwan, July 25, 2024 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of fiber-optic access network products for the internet datacenter, cable broadband, telecom and fiber-to-the-home (FTTH) markets, today confirmed that its faci...

ICFI - ICF to Present at the Canaccord Genuity 44th Annual Growth Conference

ICF to Present at the Canaccord Genuity 44th Annual Growth Conference PR Newswire RESTON, Va. , July 25, 2024 /PRNewswire/ -- ICF (NASDAQ: ICFI), a global consulting and technology services provider, today announced its participation at the Canaccord Genuity...

BOC - Boston Omaha Corporation Announces Adoption of $20 Million Class A Common Stock Repurchase Program

Boston Omaha Corporation (NYSE: BOC) (the “Company”) announced today that its Board of Directors (the “Board”) approved a share repurchase program under which the Company can repurchase up to $20,000,000 of its Class A common stock through September 30, 2025 throug...

INO - Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107 PR Newswire Data reviewed complies with standards that would be used to evaluate an EU Marketing Authorization Applic...

GILD - Gilead Sciences to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2024 financial results and guidance will be released on Thursday, August 8, 2024, after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’...

FOSL - Fossil Group, Inc. Announces Date for Second Quarter 2024 Earnings Release and Conference Call

RICHARDSON, Texas, July 25, 2024 (GLOBE NEWSWIRE) -- Fossil Group, Inc. (NASDAQ: FOSL) announced today that it will report second quarter 2024 financial results after market close on Thursday, August 8, 2024, followed by a conference call to discuss the results at 5:00 p.m. ET the same day. The c...

FISI - Financial Institutions, Inc. Announces Second Quarter 2024 Financial Results

WARSAW, N.Y., July 25, 2024 (GLOBE NEWSWIRE) -- Financial Institutions, Inc. (NASDAQ: FISI) (the "Company," "we" or "us"), parent company of Five Star Bank (the "Bank") and Courier Capital, LLC ("Courier Capital"), today reported financial and operational results for the second quarter ended June...

FDUS - Fidus Investment Corporation Schedules Second Quarter 2024 Earnings Release and Conference Call

EVANSTON, Ill., July 25, 2024 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ: FDUS) (“Fidus” or the “Company”) today announced that it will report its second quarter 2024 financial results on Thursday, August 1, 2024 after the close of the financial marke...

EXPO - Exponent Reports Second Quarter 2024 Financial Results

MENLO PARK, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2024 ended June 28, 2024. “We are pleased with the outcomes of efforts to align our operating model with market demand, evidenced...

Previous 10 Next 10